Literature DB >> 11069974

Neuroprotective role of dopamine against hippocampal cell death.

Y Bozzi1, D Vallone, E Borrelli.   

Abstract

Glutamate excitotoxicity plays a key role in the induction of neuronal cell death occurring in many neuropathologies, including epilepsy. Systemic administration of the glutamatergic agonist kainic acid (KA) is a well characterized model to study epilepsy-induced brain damage. KA-evoked seizures in mice result in hippocampal cell death, with the exception of some strains that are resistant to KA excitotoxicity. Little is known about the factors that prevent epilepsy-related neurodegeneration. Here we show that dopamine has such a function through the activation of the D2 receptor (D2R). D2R gene inactivation confers susceptibility to KA excitotoxicity in two mouse strains known to be resistant to KA-induced neurodegeneration. D2R-/- mice develop seizures when administered KA doses that are not epileptogenic for wild-type (WT) littermates. The spatiotemporal pattern of c-fos and c-jun mRNA induction well correlates with the occurrence of seizures in D2R-/- mice. Moreover, KA-induced seizures result in extensive hippocampal cell death in D2R-/- but not WT mice. In KA-treated D2R-/- mice, hippocampal neurons die by apoptosis, as indicated by the presence of fragmented DNA and the induction of the proapoptotic protein BAX. These results reveal a central role of D2Rs in the inhibitory control of glutamate neurotransmission and excitotoxicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069974      PMCID: PMC6773169     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches.

Authors:  P E Schauwecker; O Steward
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

2.  Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death.

Authors:  R S Morrison; H J Wenzel; Y Kinoshita; C A Robbins; L A Donehower; P A Schwartzkroin
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

3.  Fos induction following systemic kainic acid: early expression in hippocampus and later widespread expression correlated with seizure.

Authors:  J O Willoughby; L Mackenzie; A Medvedev; J J Hiscock
Journal:  Neuroscience       Date:  1997-03       Impact factor: 3.590

4.  Dopamine decreases the calcium-activated afterhyperpolarization in hippocampal CA1 pyramidal cells.

Authors:  R C Malenka; R A Nicoll
Journal:  Brain Res       Date:  1986-08-06       Impact factor: 3.252

Review 5.  Steroid hormones and excitability in the mammalian brain.

Authors:  M Joëls
Journal:  Front Neuroendocrinol       Date:  1997-01       Impact factor: 8.606

6.  Dopamine changes the shape of action potentials in hippocampal pyramidal cells.

Authors:  S Pockett
Journal:  Brain Res       Date:  1985-09-09       Impact factor: 3.252

7.  BAX is required for neuronal death after trophic factor deprivation and during development.

Authors:  T L Deckwerth; J L Elliott; C M Knudson; E M Johnson; W D Snider; S J Korsmeyer
Journal:  Neuron       Date:  1996-09       Impact factor: 17.173

8.  Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases.

Authors:  L Y Wang; M W Salter; J F MacDonald
Journal:  Science       Date:  1991-09-06       Impact factor: 47.728

Review 9.  Limbic-cortical neuronal damage and the pathophysiology of schizophrenia.

Authors:  J G Csernansky; M E Bardgett
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

10.  c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities.

Authors:  T D Halazonetis; K Georgopoulos; M E Greenberg; P Leder
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

View more
  31 in total

1.  Neuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms.

Authors:  Luisa de Lemos; Felix Junyent; Antoni Camins; Rubén Darío Castro-Torres; Jaume Folch; Jordi Olloquequi; Carlos Beas-Zarate; Ester Verdaguer; Carme Auladell
Journal:  Mol Neurobiol       Date:  2017-06-29       Impact factor: 5.590

2.  Neurochemical modulation involved in the beneficial effect of liraglutide, GLP-1 agonist on PTZ kindling epilepsy-induced comorbidities in mice.

Authors:  Prashant Koshal; Puneet Kumar
Journal:  Mol Cell Biochem       Date:  2016-03-10       Impact factor: 3.396

3.  Effects of oxcarbazepine on monoamines content in hippocampus and head and body shakes and sleep patterns in kainic acid-treated rats.

Authors:  Alfonso Alfaro-Rodríguez; Rigoberto González-Piña; Antonio Bueno-Nava; Emilio Arch-Tirado; Alberto Ávila-Luna; Rebeca Uribe-Escamilla; Javier Vargas-Sánchez
Journal:  Metab Brain Dis       Date:  2011-07-26       Impact factor: 3.584

4.  Downregulation of dopamine D₁ receptors and increased neuronal apoptosis upon ethanol and PTZ exposure in prenatal rat cortical and hippocampal neurons.

Authors:  Muhammad Imran Naseer; Ikram Ullah; Mahmood Rasool; Shakeel Ahmed Ansari; Ishfaq Ahmed Sheikh; Fehmida Bibi; Adeel Gulzar Chaudhary; Mohammed H Al-Qahtani; Myeong Ok Kim
Journal:  Neurol Sci       Date:  2014-05-09       Impact factor: 3.307

5.  ROCK/PKA Inhibition Rescues Hippocampal Hyperexcitability and GABAergic Neuron Alterations in a Oligophrenin-1 Knock-Out Mouse Model of X-Linked Intellectual Disability.

Authors:  Irene Busti; Manuela Allegra; Cristina Spalletti; Chiara Panzi; Laura Restani; Pierre Billuart; Matteo Caleo
Journal:  J Neurosci       Date:  2020-02-25       Impact factor: 6.167

6.  Mice with deficiency of G protein gamma3 are lean and have seizures.

Authors:  William F Schwindinger; Kathryn E Giger; Kelly S Betz; Anna M Stauffer; Elaine M Sunderlin; Laura J Sim-Selley; Dana E Selley; Sarah K Bronson; Janet D Robishaw
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

7.  The loss of circadian PAR bZip transcription factors results in epilepsy.

Authors:  Frédéric Gachon; Philippe Fonjallaz; Francesca Damiola; Pascal Gos; Tohru Kodama; Jozsef Zakany; Denis Duboule; Brice Petit; Mehdi Tafti; Ueli Schibler
Journal:  Genes Dev       Date:  2004-06-02       Impact factor: 11.361

8.  Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.

Authors:  Gerard J O'Sullivan; Mark Dunleavy; Kerstin Hakansson; Mario Clementi; Anthony Kinsella; David T Croke; John Drago; Allen A Fienberg; Paul Greengard; David R Sibley; Gilberto Fisone; David C Henshall; John L Waddington
Journal:  Neuropharmacology       Date:  2008-02-21       Impact factor: 5.250

9.  Dopamine D2 receptor availability is linked to hippocampal-caudate functional connectivity and episodic memory.

Authors:  Lars Nyberg; Nina Karalija; Alireza Salami; Micael Andersson; Anders Wåhlin; Neda Kaboovand; Ylva Köhncke; Jan Axelsson; Anna Rieckmann; Goran Papenberg; Douglas D Garrett; Katrine Riklund; Martin Lövdén; Ulman Lindenberger; Lars Bäckman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-23       Impact factor: 11.205

10.  Impaired neurogenesis, learning and memory and low seizure threshold associated with loss of neural precursor cell survivin.

Authors:  Vanessa Coremans; Tariq Ahmed; Detlef Balschun; Rudi D'Hooge; Astrid DeVriese; Jonathan Cremer; Flavia Antonucci; Michaël Moons; Veerle Baekelandt; Veerle Reumers; Harold Cremer; Amelia Eisch; Diane Lagace; Tom Janssens; Yuri Bozzi; Matteo Caleo; Edward M Conway
Journal:  BMC Neurosci       Date:  2010-01-05       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.